October 21 has been a day marked by significant events that have shaped our world across centuries and continents.Turning ...
The first patients have been dosed in a phase 3 trial of an mRNA-based seasonal influenza vaccine developed by Pfizer and BioNTech, which may offer quicker production and greater efficacy than shots ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback